4.7 Article

Synthesis and crystal structures of D-annulated pentacyclic steroids: looking within and beyond AR signalling in prostate cancer

期刊

CRYSTENGCOMM
卷 24, 期 11, 页码 2089-2099

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1ce01417j

关键词

-

向作者/读者索取更多资源

Carbocyclic steroids with D-annulation at the 16 alpha and 17 alpha positions, along with a 5-membered ring E, can be easily synthesized through the interrupted Nazarov cyclization. These steroids exhibit geometries that perfectly match the active site of the human androgen receptor. Experimental results also demonstrate the antiproliferative activity and inhibition of the AR pathway in prostate cancer cells, providing insights for the development of novel drugs targeting nuclear receptors in cancer cells.
Carbocyclic steroids D-annulated at 16 alpha and 17 alpha positions with a 5-membered ring E are easily accessible via the interrupted Nazarov cyclization. Three steroid series have been structurally studied: chlorine-containing D-annulated pentacyclic steroids 2, their reduced derivatives 3 and their synthetic precursors - benzylidines of tetracyclic steroids 1. The presence of two conformers for pentacyclic steroids 2 and 3 have been found in crystals, where formation is evidently caused by the conformational flexibility of the ring E. Geometries obtained from X-ray diffraction experiments have been used as the initial ones for semi-empirical and ab initio quantum chemical calculations to confirm the reproducibility of the steroids' geometries by these methods and further used for docking studies against the human androgen receptor ligand-binding domain. The docking results have confirmed that the geometries of the studied D-annulated pentacyclic steroids perfectly match the human androgen receptor active site. Geometry analysis of docking results allowed us to explain the influence of subtle structural differences in series 2 and 3 on the ligand binding energy. Compounds with the highest binding energies have been studied in experiments on AR-positive 22Rv1 prostate cancer cells. Selected steroids revealed antiproliferative potency and inhibited AR pathways in 22Rv1 prostate cancer cells, including downregulation in NKX3.1 and PSA expression. A combination of pentacyclic steroid 2d with non-steroidal antiandrogen bicalutamide exhibited significant antiproliferative effects in 22Rv1 cells. The obtained results for this family of pentacyclic steroids provides insights for further structure-activity relationship studies towards novel drugs targeting nuclear receptors in cancer cells. Pentacyclic steroids are of great interest for the development of innovative therapeutic approaches in the treatment of prostate cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据